Cargando…
Effective treatment with Tocilizumab in a COVID-19 patient on maintenance hemodialysis: A case report
Coronavirus disease 2019 (COVID-19) is a rapidly spreading infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). The management of this disease remains a challenge particularly in certain subgroups of patients such in hemodialysis patients who have highe...
Autores principales: | Nourié, Nicole, Chamaa, Mohamed Ammar, Mouawad, Sarah, Kotait, Micheline Mia, Finianos, Serge, Azar, Hiba, Chelala, Dania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838846/ https://www.ncbi.nlm.nih.gov/pubmed/33502716 http://dx.doi.org/10.1007/s13730-021-00577-y |
Ejemplares similares
-
Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study
por: Asmar, Jihane, et al.
Publicado: (2023) -
Routine laboratory testing in hemodialysis: how frequently is it needed?
por: Chidiac, Claudia, et al.
Publicado: (2022) -
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
por: Nourié, Nicole, et al.
Publicado: (2022) -
High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K(2), A pre-post intervention clinical trial
por: Aoun, Mabel, et al.
Publicado: (2017) -
Safe and Efficient Use of Tocilizumab in Rheumatoid Arthritis Patient on Maintenance Hemodialysis: A Case Report
por: Kilić, Paula, et al.
Publicado: (2023)